Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Breast. 2022 Dec;66:77-84. doi: 10.1016/j.breast.2022.09.006. Epub 2022 Sep 28.
Breast. 2022.
PMID: 36206609
Free PMC article.
Clinical Trial.
Is OSNA better than imprint cytology for intraoperative diagnosis of cancer involvement of axillary sentinel node in breast cancer?
Luna-Tomás MA, Solà-Suárez M, Mariscal-Martínez A, Castellà-Fernández E, Martínez-Román S, Pascual-Miguel I, Quiroga-García V, Julián-Ibáñez JF.
Luna-Tomás MA, et al. Among authors: quiroga garcia v.
Breast. 2018 Apr;38:181-187. doi: 10.1016/j.breast.2018.02.002. Epub 2018 Feb 16.
Breast. 2018.
PMID: 29455041
Item in Clipboard
Primary Hormone Therapy in Elderly Women with Hormone-Sensitive Locoregional Breast Cancer: Endocrine Therapy Alone Is a Reasonable Alternative in Selected Patients.
Quiroga-García V, Cirauqui-Cirauqui B, Bugés-Sánchez C, Luna-Tomás MÁ, Castellà-Fernández EM, Mariscal-Martínez A, Margelí-Vila M.
Quiroga-García V, et al.
Breast Care (Basel). 2015 Jul;10(3):179-83. doi: 10.1159/000382112. Epub 2015 May 22.
Breast Care (Basel). 2015.
PMID: 26648829
Free PMC article.
Item in Clipboard
Use of denosumab in a dialysis patient with bone metastases from breast cancer and hepatorenal polycystic disease: a case report.
Quiroga García V, Cirauqui Cirauqui B, Tobey Robaina L, López Sisamon D, Hardy-Werbin M, Blanca AB, Margelí Vila M.
Quiroga García V, et al.
Anticancer Drugs. 2016 Jun;27(5):464-9. doi: 10.1097/CAD.0000000000000339.
Anticancer Drugs. 2016.
PMID: 26813866
Item in Clipboard
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups.
Guigay J, et al.
Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5.
Lancet Oncol. 2021.
PMID: 33684370
Clinical Trial.
Item in Clipboard
Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice.
Antolín-Novoa S, Blanco-Campanario E, Antón A, Gallegos-Sancho MI, Pérez-Carrión R, Peláez I, Galán-Brotons A, de la Cruz-Merino L, Murías-Rosales A; SmallHER Study Group.
Antolín-Novoa S, et al.
Clin Transl Oncol. 2015 Nov;17(11):862-9. doi: 10.1007/s12094-015-1316-9. Epub 2015 Jun 24.
Clin Transl Oncol. 2015.
PMID: 26103952
Item in Clipboard
Cite
Cite